Male infertility affects ~7% of men in Western societies, but its causes remain poorly 62 understood. The most clinically severe form of male infertility is non-obstructive azoospermia 63 (NOA), which is, in part, caused by an arrest at meiosis, but so far only few genes have been 64 reported to cause germ cell arrest in males. To address this gap, whole exome sequencing 65 was performed in 60 German men with complete meiotic arrest, and we identified in three 66 unrelated men the same homozygous frameshift variant c.676dup (p.Trp226LeufsTer4) in 67 M1AP, encoding meiosis 1 arresting protein. Then, with collaborators from the International 68
Introduction 85
Around 7% of all men in Western societies are infertile, 1 which is primarily diagnosed by 86 semen analysis, comprising as the most relevant parameters sperm concentration and count. 87
More than 10% of all infertile men exhibit azoospermia, 2 which is defined as the absence of 88 spermatozoa in the ejaculate and constitutes the most clinically severe form of male 89 infertility, resulting in zero chance of natural conception. 3 Azoospermia is further classified 90 into obstructive and non-obstructive azoospermia (OA and NOA, respectively). In a large 91 fraction of NOA cases a genetic origin is assumed, 4 such that patients with azoospermia are 92 routinely screened for chromosomal aberrations and Y-chromosomal azoospermia factor 93 (AZF) microdeletions. However, these diagnostic tests only establish a reason for the 94 azoospermia in 15-20% of cases. 2 95 NOA can be stratified into four groups based on histological analysis of the seminiferous 96 tubules: normal spermatogenesis (a finding which indicates OA and post-testicular defects), 97 hypospermatogenesis, Sertoli-cell only (SCO), and maturation arrest. Maturation arrest most 98 frequently presents as meiotic arrest, in which spermatocytes are the most advanced germ 99 cell types in the testes. 5 If germ cell arrest is only partial, some mature spermatozoa will 100 develop, meaning that men with partial germ cell arrest can become parents by undergoing 101 testicular biopsy and sperm extraction (TESE) and then using the extracted sperm in 102 assisted reproductive technology (ART). By contrast, if germ cell arrest is complete, no 103 mature spermatozoa will develop and TESE cannot be successful. However, thus far, germ 104 cell arrest can only be reliably diagnosed by testicular biopsy, i.e., after the surgery, 105 emphasizing the urgent need for better diagnostic tests before biopsy to avoid unnecessary 106 and unsuccessful surgical procedures. 107
Better diagnostic workup could be developed upon identifying causal genes or mutations that 108 promote germ cell arrest. Recently, the first monogenic alterations associated with germ cell 109 arrest in human males have been described. However, according to a standardized 110 assessment of clinical validity, the X-linked gene TEX11 6 (MIM: 300311) currently remains 111 the only gene with strong evidence. 7 Given the large number of genes known to cause 112 meiotic arrest in mice, the vast majority of causal mutations causing this phenotype in 113
humans are yet to be identified. 114
To this end, we first screened the exomes of well-characterized patients with complete, 115 bilateral germ cell arrest at the spermatocyte stage for variants in testis-expressed genes. As 116 a result, we identified biallelic loss-of-function (LoF) variants in three unrelated infertile men 117 in the gene encoding meiosis 1 arresting protein (M1AP). Furthermore, by screening two 118 independent cohorts, we found the same homozygous LoF variant in a patient with 119 hypospermatogenesis predominantly displaying meiotic arrest, and we found likely 120 pathogenic missense variants in M1AP in two NOA patients. Additionally, we identified a 121 homozygous missense variant in M1AP segregating with azoospermia in five infertile men in 122 a consanguineous Turkish family. M1ap is primarily expressed in male germ cells during 123 spermatogenesis, and its knockout in male mice leads to infertility due to meiotic arrest. 8,9 124 Our results, together with previously published findings, provide sufficient evidence that 125 M1AP plays an essential role during spermatogenesis and its loss causes NOA in a 126 considerable proportion of infertile men. This allows for a better understanding of the 127 molecular basis of meiotic arrest and improved counseling and treatment of infertile couples. 128 129
Subjects and Methods 130

Study cohorts 131
Chromosomal aberrations and AZF deletions were excluded in advance. Four out of 64 140 patients were diagnosed with a LoF variant in TEX11 previously (Yatsenko et al. 2015 As a next step, a study cohort of 99 men with unexplained azoospermia (N = 55) or severe 150 oligozoospermia (N = 44) who presented at Radboud University Medical Center 151 (Radboudumc, Nijmegen) was screened for biallelic variants in M1AP. In parallel, we 152 screened the whole exome sequencing data produced within the GEMINI study 153 (https://gemini.conradlab.org/) of 979 unrelated men with unexplained NOA for biallelic 154 variants in M1AP. In both cohorts, chromosomal aberrations, AZF deletions and CFTR-155 mutations had been excluded. 156
Additionally, we performed whole exome sequencing in two brothers with unexplained 157 infertility from a consanguineous Turkish family and one fertile brother. The index patient 158 T1024 (V.2; Figure 3A ) and his wife presented at Uludag University Faculty of Medicine 159
Hospital because of couple infertility. Semen analysis revealed azoospermia, and 160 chromosomal aberrations as well as AZF deletions were excluded. The patient reported that 161 he had an infertile brother and three further infertile male relatives ( Figure 3A After trimming, Cutadapt v1.15 was used to remove the remaining adapter sequences and 179 primers 11 . Sequence reads were aligned against the reference genome GRCh37.p13 using 180 BWA Mem v0.7.17 12 . We excluded duplicate reads and reads that mapped to multiple 181 locations in the genome from further analysis. Small insertions/deletions (indels) and single 182 nucleotide variations were identified and quality-filtered by GATK toolkit v3.8 with 183
HaplotypeCaller, in accordance with the best practice recommendations. 13 Table S1 . 219
Quantitative PCR analysis 221
To exclude a hemizygous deletion on the other allele, quantitative PCR (qPCR) of exon 5 222 was performed on gDNA of the three patients from the MERGE study (M330, M864, M1792) 223 carrying the variant c.676dup. qPCR was carried out in 96-well plates on the LightCycler 480 224 using the manufacturer's default settings. The ALB (albumin) gene was used for 225 normalization. The reactions were performed in triplicates using the SensiMix Real-Time 226 PCR Kit (Bioline). The PCR consisted of an initial incubation step at 95°C for 10 min followed 227 by 40 cycles of 95°C for 15 sec, 60°C for 30 sec and 72°C for 15 sec. Baseline and threshold 228 values were automatically detected using the LightCycler software. Primers are provided in 229 Table S1 . GmbH, Birkenau, Germany). Subsequently, 5 µm sections were stained with periodic acid-236 Schiff (PAS) as previously described. 20 237
We attempted to establish immunohistochemistry as well as Western blot analyses with 238 commercially available M1AP antibodies (#PA5-31627, ThermoFisher Scientific, 239
Langenselbold, Germany and #HPA045420, Sigma-Aldrich, Munich, Germany). These were 240 selected based on available data from the manufacturers and the human protein atlas (see 241
Suppl. Data for details). 242 243
Search for M1AP variants in women with premature ovarian insufficiency 244
Because some genes have been reported to be associated with both male and female 245 infertility, we screened 101 women diagnosed with unexplained premature ovarian 246 insufficiency (POI) (62 with isolated POI and 39 with ovarian dysgenesis) by direct Sanger 247 sequencing of the full coding region. Details of a part of this cohort (N = 25) have been 248 published previously. 21 The additional 76 patients followed the same in-and exclusion 249 criteria. 250
251
Results 252
Identification of M1AP as a candidate gene and follow-up study in three independent groups 253
In the initial MERGE study, the WES data of 60 highly selected, azoospermic infertile 254 patients with unexplained, complete, bilateral germ cell arrest at the spermatocyte stage 255 were screened for rare (MAF < 0.01 according to gnomAD-database 22 ), biallelic LoF variants. 256
Two patients were subsequently excluded from this study, because likely causal variants in 257 other genes had been identified in parallel: patient M870 had compound heterozygous 258 variants in STAG3, 23 and patient M1401 had a heterozygous LoF variant in SYCP2. 24 The 259 prioritized genes in the remaining 58 patients were analyzed with regard to the level of 260 expression in the testes. A literature search was performed to identify genes with previous 261 evidence for an association with infertility in either human or model species. The highest 262 prioritized gene was M1AP because three unrelated men (M330, M864, M1792, Figure 1 ) 263 carried the same potentially homozygous LoF variant (c.676dup, MAF = 0.0021, no 264 homozygotes in gnomAD 22 ), the M1AP protein displays the highest expression in the testis, 265 and it has been shown to play a crucial role in spermatogenesis in mice. 8, 9 The variant 266 c.676dup is located in exon 5 of 11 and causes a frameshift and premature stop codon 267 (p.Trp226LeufsTer4), as confirmed by testicular cDNA sequencing of exons 5 of patient 268 M864 ( Figure S2B ). Quantitative PCR analysis of M1AP exon 5 excluded an intragenic 269 deletion and, thus, confirmed homozygosity for c.676dup in all patients (Table S2) In parallel, and independent of the identification of M1AP in the MERGE study, WES was 298 performed in two infertile, azoospermic brothers from a consanguineous Turkish family as 299 well as their fertile brother ( Figure 3A) . The data were analyzed focusing on rare 300 homozygous variants, which were shared between the infertile brothers but not found in the 301 fertile brother. The two affected men carried rare, homozygous missense variants in the 302 autosomal genes AMPD2, CELSR2, CEP164, and M1AP as well as rare hemizygous 303 variants in the X-linked genes ATG4A and ENOX2. Of these genes, M1AP is the only one 304 that has been described in the context of infertility. Both infertile men carried the 305 homozygous missense variant c.1166C>T (p.(Pro389Leu); MAF = 0.00001) in M1AP, which 306 was found in a heterozygous state in the fertile brother. No homozygous carriers of this 307 variant have been described so far in any public databases. Subsequently, this variant was 308 also found in a homozygous state in three additional infertile males from the same family. 309
Additionally, after recruiting and examining nine fertile members of the Turkish family, we 310 found that none of them were homozygous for this variant. We did identify both a fertile man 311 and a fertile woman (IV.13 and V.6 in Figure 3A , respectively) as heterozygous carriers of 312 the same variant (example result of Sanger sequencing for subject V.6 shown in Figure 3B ). 313
Clinical data was only available for the index case T1024, and this patient had borderline 314 follicle stimulating hormone (FSH, 8.3 U/L) as well as testicular volume (15 mL both left and 315 right) ( Table 1 ). This combination is often found in azoospermic men with germ cell arrest, 316 while most other infertile NOA patients lacking advanced germ cells have elevated FSH 317 levels because of the pituitary-gonadal feedback loop. 318
In addition, we analyzed all identified variants from the respective WES analyses in each 319 patient individually utilizing the PSAP pipeline. This pipeline enabled us to rank all variants 320 per patient, following the prioritization criteria (MAF ≤ 0.01, PopScore ≤ 0.005 and CADD 321 ≥ 20). The biallelic M1AP LoF variants were ranked in the first position for patient M1792 and 322 in the third position for patients M330 and M864 in the discovery cohort (Table S3 ). The four 323 patients identified in the follow-up analyses exhibited highly ranked M1AP variants as well: 324 position 17 in patient RU01691, position eleven in patient Y126, position 33 in patient P86 325 and position 12 in T1024, respectively. 326
M1AP immunostaining and Western blot 328
After optimization, both commercial antibodies resulted in a specific signal in 329 immunohistochemistry ( Figure S3/4 ). However, both antibodies seem not to pick up M1AP 330 but a different target. First of all, similar signals could also be detected in two of the patients 331 carrying the homozygous frameshift variant c.676dup, which lead to a disruption of the 332 supposed epitope of the antibodies presumed to reside in the region of or downstream of the 333 variant. Moreover, the Western blot did not only result in detection of a band in testis lysate 334 but also in a kidney lysate where M1AP is not expressed and, last not least, the bands were 335 not at the expected size ( Figure S5 ). Therefore, we also reached out to the colleagues who 336 published the M1AP knockout mice and Western blot staining with a self-raised antibody, 9 337 but were unsuccessful in getting in contact. We have identified a total of eleven patients from four independent cohorts and provide 361 convincing evidence that biallelic variants in M1AP are associated with predominantly germ 362 cell arrest in otherwise healthy men. Previously, disruption of M1ap has been shown to 363 cause a highly similar testicular phenotype in mice. The M1ap knockout mice showed severe 364 oligozoospermia due to predominantly tubular defects with no germ cells beyond the 365 spermatocyte stage, consequently resulting in infertility. 9 So far, only very few other genes 366 with mutations leading to germ cell arrest in both men and mice and validated in independent 367 cohorts have been published. The first was the X-chromosomal gene TEX11, 6,26 which is, 368 according to a current structured assessment, one of only a few genes with strong clinical 369 validity for an association with NOA. 7 Another example is the autosomal gene STAG3, which 370 has only recently been described in publications by us and others in parallel, 23,27 and its 371 clinical validity is currently 'moderate'. Most of the proteins involved in DNA recombination, 372 including M1AP, are highly evolutionarily conserved. 8 This suggests that these genes are not 373 tolerant to variation likely due to an infertility phenotype. Because of the previously available 374 evidence from mice and because we replicated our primary finding in several independent 375 groups as well as a consanguineous family, M1AP immediately reaches a 'moderate' clinical 376 validity (Table S4 ). This clearly underlines the strength of such collaborative efforts, which 377 have only recently been established in the context of the previously slowly progressing field 378 of male infertility genetics. 379
From our initial cohort of 64 men with complete bilateral meiotic arrest, we also identified 380 likely causal variants in three other genes, namely TEX11, STAG3 and SYCP2. These 381 results have been reported elsewhere. 6,23,24 Among the remaining group of 58 men, we 382 identified three unrelated patients with the same homozygous frameshift variant c.676dup 383 (p.Trp226Leufs*4) in M1AP. Thus, up to 5% of men affected by male infertility, non-384 obstructive azoospermia and meiotic arrest (3 out of 64) carry causal mutations in M1AP, 385 making this a comparably common reason for germ cell arrest at the spermatocyte stage like 386 TEX11 mutations with 6% (4 out of 64) in this selected patient population. Overall, M1AP 387 contributes to less than 1% of the highly heterogeneous NOA cases (0.4%, 6 out of 1548 388 patients in total across the three screened cohorts: 514 and 979 from the MERGE and 389 GEMINI studies, respectively, and 55 from the Nijmegen trio cohort). 390
The fact that the same frameshift variant c.676dup was also found to be homozygous in 391 RU01691 from the Netherlands and heterozygous in patient Y126 from Portugal suggests 392 that this variant is relatively prevalent in European populations. The likely explanation for its 393 relative commonness is that this mutation is a founder mutation present in men of European 394
ancestry. Yet, although we found this frameshift variant four times in a homozygous state in 395 unrelated men with germ cell arrest, it is a rarely described variant in global large databases. 396
The gnomAD database does not list any homozygous men, and the maximum allele 397 frequency is 0.0038 in the European (non-Finnish) population. In our control cohort of 285 398
German men with normal sperm production, we detected five heterozygous carriers of 399 c.676dup, corresponding to an allele frequency of 0.0088. This difference in allele frequency 400 can be explained either by the relatively small size of the control cohort or by an enrichment 401 in the population attending the CeRA in Münster, i.e., of Westphalian origin. In the larger 402 Dutch cohort of 3347 fertile couples, 30 heterozygous carriers were found, corresponding to 403 an allele frequency of 0.0022. 404
The relevance of the homozygous frameshift variant c.676dup in M1AP found in four patients 405 is underlined by the very low PopScore (9.7x10 -7 ) obtained by PSAP and the high 406 prioritization of the M1AP variants in all analyzed patients who carried the variants 407 (Table S3 ). Moreover, the expected mode of inheritance for this gene is autosomal recessive 408 according to a general prediction, 28 fitting our observations of biallelic variants in the affected 409
patients. 410
This frameshift variant c.676dup very likely causes a premature stop codon four amino acids 411 downstream (p.Trp226Leufs*4). This could result either in an altered and severely truncated 412 protein with 230 amino acids (normal protein length: 530 amino acids), or in nonsense-413 mediated decay (NMD) of the mRNA. Analysis of patient M864's testis RNA resulted in an 414 equal band compared to control testis RNA, and we therefore exclude elimination through 415 NMD ( Figure S2A ). Unfortunately, both protein analysis via Western blot and 416 immunohistological stainings failed because of the lack of suitable antibodies raised against 417 M1AP (Figures S3, S4, and S5) . 418
In addition to the heterozygous frameshift c.676dup, patient Y126 carries the substitution 419 c.949G>A. The missense variant replaces the highly conserved (up to platypus; Figure 2C ) 420 neutral and nonpolar amino acid glycine with the larger, positively charged amino acid 421 arginine (p. (Gly317Arg) ). Based on conservation information, the variation in this position is 422 highly likely to impair M1AP protein function. 19 The introduction of a charge may cause the 423 repulsion of interaction partners or of other positively charged residues. In addition, the 424 altered torsion angles may have an influence on the correct conformation and disturb the 425 local structure of the protein. Correspondingly, the amino acid change p.(Gly317Arg) is 426 predicted to be deleterious by all in silico algorithms. 427
Patient P86 carries two missense variants in M1AP. The mutation c.1289T>C leads to a 428 substitution of the hydrophobic amino acid leucine, which is predicted to be located in an 429 alpha helix, with the less hydrophobic amino acid proline (p.(Leu430Pro)). 19 Because proline 430 is an alpha helix breaker, the alteration likely has severe effects on protein structure. This 431 change is predicted to be disease causing by all in silico programs. Furthermore, leucine at 432 position 430 is a highly conserved amino acid (up to platypus; Figure 2D ). The substitution 433 c.148T>C replaces the polar amino acid serine at position 50 with the nonpolar amino acid 434 proline (p. (Ser50Pro) ). Again, the wildtype residue is predicted to be located in an alpha 435 helix, and, therefore, its substitution by a proline likely has severe effects on protein structure 436 and function. 19 Although the in silico algorithms SIFT and MutationTaster predict this change 437 as being tolerated and as a polymorphism, the variant has not previously been described in 438 any population, which supports a pathogenic impact. Moreover, this amino acid is likewise 439 highly conserved (up to platypus; Figure 2D ). 440
We add another layer of evidence that M1AP missense variants cause NOA with data from a Figure 3C ). Proline is known to have a 450 rigid structure, giving a protein a specific conformation, which could be disrupted by 451 substitution with leucine. 19 Accordingly, the amino acid exchange is predicted to be 452 pathogenic by all in silico programs. 453
The possible effects of the detected missense variant on post-translational modifications and 454 folding of the M1AP protein are difficult to assess and, thus, inherently uncertain. 455
Unfortunately, the structure of the M1AP protein is currently unknown and it is impossible to 456 predict functional domains of the M1AP protein with high reliability. Moreover, the specific 457 molecular function of M1AP remains to be elucidated in subsequent studies. 458
The process of meiosis is in part similar between males and females, but orchestrated highly 459 differently concerning its timing. Thus far, only few genes have been reported to impair male 460 as well as female meiosis. As an example, variants in STAG3 had previously been reported 461 to cause POI 29 and now have recently been shown to also cause NOA and meiotic arrest. 23,27 462 M1AP is predominantly expressed in the adult testis (GTEx), but also reported to be 463 expressed in the fetal mouse ovary. 8 However, the structure of ovaries in female M1ap 464 knockout mice appeared normal and fertility was preserved. 9 Concordantly, we did not 465 identify any relevant variants in M1AP in 101 women affected by POI. Still, we neither found 466 a fertile woman carrying a homozygous LoF variant in the large Dutch trio cohort. From this 467 data, we cannot exclude that variants in M1AP may be a rare cause also for POI, but it 468 seems likely that M1AP is only required for male meiosis. 469
The common phenotype among our patients is NOA, and four out of six with testicular 470 histology available had either complete (N = 3) or predominant (N = 1) meiotic arrest, i.e., 471 germ cell arrest at the spermatocyte stage. A similar phenotype was observed in mice with 472 disruption of M1ap, 9 but these mice had some sperm in their semen, i.e., severe 473 oligozoospermia. This fact is not inconsistent with our findings, as the authors of the study 474 described mice exhibiting variable efficiency of M1ap disruption: Some mice had no apparent 475 wildtype protein, while others displayed reduced levels of the M1AP protein. 9 If the authors 476 had achieved a complete biallelic knockout of M1ap in all mice, representing complete 477 meiotic arrest, one would expect azoospermia to result. 478
We did not identify biallelic M1AP variants in any other male infertility phenotypes such as 479 SCO or severe oligozoospermia, and no subjects with homozygous M1AP LoF variants are 480 present in gnomAD (>140,000 subjects). In conclusion, the presented data strongly suggests 481 that both homozygous LoF and missense variants in M1AP impairing its protein as well as 482 compound heterozygosity for either variant type lead to NOA. M1AP disruption is associated 483 primarily with germ cell arrest at meiosis/spermatocyte stage, but it may also be compatible 484 with some rare instances of further progressed spermatogenesis. Based on our data, we 485 cannot reliably predict the probability of successful sperm retrieval by testicular biopsy and 486 TESE among men with disrupted M1AP, but if we extrapolate the findings from the men 487 reported here, TESE success is quite low (1 of 6, <20%). 488
Our finding that biallelic M1AP mutations cause predominantly germ cell arrest at the 489 spermatocyte stage in infertile men provides further evidence that meiotic arrest is often of 490 monogenic origin. According to the structured assessment presented here, M1AP has 491 considerable clinical validity for causing NOA and could potentially be used as a screening 492 marker before testicular biopsy to estimate the chances of successful TESE. Reference values: FSH 1-7 IU/L, LH 2-10 IU/L, T >12 nmol/L, TV >15 mL per testis. 633
